Characteristics, management and five-year outcomes of patients with high risk, stable multivessel coronary heart disease

Kardiologia Polska

Volumn 72, Issue 3, 2014, Pages 262-268

  Krȩcki, Radosław ^a   Arazińska, Agata ^a   Peruga, Jan Zbigniew ^a   Plewka, Michał ^a   Kasprzak, Jarosław Damian ^a   Krzemińska Pakuła, Maria ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Multivessel coronary artery disease; Prognosis; Stable; Treatment

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENSINI SCORE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HIGH RISK PATIENT; HUMAN; KIDNEY FAILURE; MAJOR ADVERSE CARDIAC AND CEREBROVASCULAR EVENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVESSEL CORONARY ARTERY DISEASE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REVASCULARIZATION; SURVIVAL; THORAX PAIN; COMPARATIVE STUDY; DRUG ELUTING STENT; HEALTH STATUS; MYOCARDIAL INFARCTION; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; TREATMENT OUTCOME;

EID: 84897126017     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/KP.a2013.0285     Document Type: Article

References (25)

1. American Heart Association. Heart Disease and Stroke Statistics - 2008 Update. American Heart Association, Dallas, Texas 2008.
2. th Ed. Sauders, United States 2005: 1281-1354.
3. Solomon AJ, Gersh BJ. Management of chronic stable angina: medical therapy, percutaneous transluminal coronary angioplasty and coronary artery bypass surgery. Lessons from the randomized trials. Ann Intern Med, 1998; 128: 216-223. (Pubitemid 28078203)
4. Serruys PW, Morice MC, Kappetein AP et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 2009; 360: 961-972.
5. Hannan EL, Wu C, Walford G et al. Drug-eluting stents vs. coronary- artery bypass grafting in multivessel coronary disease. N Engl J Med, 2008; 358: 331-341. (Pubitemid 351159232)
6. Hoffman SN, Tenbrook JA, Wolf MP et al. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one-to eight-year outcomes. J Am Coll Cardiol, 2003; 41: 1293-1304. (Pubitemid 36438990)
7. Roffi M, Angiolillo DJ, Kappetein AP. Current concepts on coronary revascularization in diabetic patients. Eur Heart J, 2011; 32: 2748-2757.
8. Booth J, Clayton T, Pepper J, et al.; on behalf of the SoS Investigators. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS). Circulation, 2008; 118: 381-388.
9. Hueb W, Lopes HN, Gersh JB et al. Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II). A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation, 2007; 115: 1082-1089. (Pubitemid 46673170)
10. Hueb W, Lopes HN, Gersh JB et al. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation, 2010; 122: 949-955.
11. Kappetein AP, Feldman TE, Mack MJ et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J, 2011; 32: 2125-2134.
12. Yusuf S, Zucker D, Peduzzi P et al. Effect of coronary artery bypass graft surgery on survival overview of 10-year results from randomized trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet, 1994; 344: 563-570. (Pubitemid 24267213)
13. Serruys PW, Ong AT, Herwerden LA et al. Five year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease. J Am Coll Cardiol, 2005; 46: 575-581.
14. Bypass Angioplasty Revascularization Investigators (BARI). Comparison of coronary bypass surgery with angioplasty in patients with multi-vessel disease. N Engl J Med, 1996; 335: 217-225.
15. Serruys PW, Ong AT, van Herwerden LA et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol, 2005; 46: 575-581. (Pubitemid 41132680)
16. Rogers WJ, Coggin CJ, Gersh BJ et al. Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery: the Coronary Artery Surgery Study (CASS). Circulation, 1990; 82: 1647-1658. (Pubitemid 20367966)
17. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation, 2005; 111: 2906-2912. (Pubitemid 40823048)
18. Stables RH. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery Trial): a randomized controlled trial. Lancet, 2002; 360: 695-700.
19. Al-Aqeedi R, Sulaiman K, Al Suwaidi J et al. Characteristics, management and outcomes of patients with acute coronary syndrome and prior coronary artery bypass surgery: findings from the second Gulf Registry of Acute Coronary Events. Interact Cardiovasc Thorac Surg, 2011; 13: 611-618.
20. Krȩcki R, Drożdż J, Szcześniak P et al. Quality of life in high-risk patients with stable multivessel coronary artery disease treated either medically or with coronary artery bypass graft surgery: 12-month follow-up. Kardiol Pol, 2010; 68: 22-30.
21. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ, 2000; 321: 73-77. (Pubitemid 30438478)
22. Henderson RA, Pocock SJ, Clayton TC et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol, 2003; 42: 1161-1170. (Pubitemid 37188334)
23. O'Rouke RA, Boden WE, Weintraub WS, Hartigan P. Medical therapy versus percutaneous coronary intervention: implications of the AVERT study and the COURAGE trial. Curr Pract Med, 1999; 2: 225-227.
24. Boden WE, O'Rourke RA, Teo KK et al. Optimal medical therapy with or without PCI for Stable Coronary Disease. N Engl J Med, 2007; 356: 1503-1516. (Pubitemid 46588415)
25. Aggarwal V, Rajpathak S, Singh M et al. Clinical outcomes based on completeness of revascularisation in patients undergoing percutaneous coronary intervention: a meta-analysis of multivessel coronary artery disease studies. EuroIntervention, 2012; 7: 1095-1102.